BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 30337059)

  • 1. Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.
    Antonarakis ES; Shaukat F; Isaacsson Velho P; Kaur H; Shenderov E; Pardoll DM; Lotan TL
    Eur Urol; 2019 Mar; 75(3):378-382. PubMed ID: 30337059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
    Graham LS; Montgomery B; Cheng HH; Yu EY; Nelson PS; Pritchard C; Erickson S; Alva A; Schweizer MT
    PLoS One; 2020; 15(5):e0233260. PubMed ID: 32453797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
    Wilczak W; Rashed S; Hube-Magg C; Kluth M; Simon R; Büscheck F; Clauditz TS; Grupp K; Minner S; Tsourlakis MC; Möller-Koop C; Graefen M; Adam M; Haese A; Wittmer C; Sauter G; Izbicki JR; Huland H; Schlomm T; Steurer S; Krech T; Lebok P
    Carcinogenesis; 2017 Jan; 38(1):19-27. PubMed ID: 27803051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair gene germline mutations in patients with prostate cancer.
    Fang B; Wei Y; Pan J; Zhang T; Ye D; Zhu Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 52(2):133-138. PubMed ID: 37283096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate.
    Schweizer MT; Cheng HH; Tretiakova MS; Vakar-Lopez F; Klemfuss N; Konnick EQ; Mostaghel EA; Nelson PS; Yu EY; Montgomery B; True LD; Pritchard CC
    Oncotarget; 2016 Dec; 7(50):82504-82510. PubMed ID: 27756888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
    Sena LA; Fountain J; Isaacsson Velho P; Lim SJ; Wang H; Nizialek E; Rathi N; Nussenzveig R; Maughan BL; Velez MG; Ashkar R; Larson AC; Pritchard CC; Adra N; Bryce AH; Agarwal N; Pardoll DM; Eshleman JR; Lotan TL; Antonarakis ES
    Oncologist; 2021 Feb; 26(2):e270-e278. PubMed ID: 33215787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of mismatch repair deficiency in prostate cancer.
    Sedhom R; Antonarakis ES
    Future Oncol; 2019 Jul; 15(20):2395-2411. PubMed ID: 31237441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients.
    Fang B; Wei Y; Zeng H; Li Y; Chen S; Zhang T; Pan J; Wang B; Wu J; Jin S; Gan H; Hu M; Zhang D; Ye D; Zhu Y
    Cancer Immunol Immunother; 2023 Jun; 72(6):1541-1551. PubMed ID: 36522531
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Antonarakis ES; Isaacsson Velho P; Fu W; Wang H; Agarwal N; Sacristan Santos V; Maughan BL; Pili R; Adra N; Sternberg CN; Vlachostergios PJ; Tagawa ST; Bryce AH; McNatty AL; Reichert ZR; Dreicer R; Sartor O; Lotan TL; Hussain M
    JCO Precis Oncol; 2020; 4():370-381. PubMed ID: 32462107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype.
    Shenderov E; Isaacsson Velho P; Awan AH; Wang H; Mirkheshti N; Lotan TL; Carducci MA; Pardoll DM; Eisenberger MA; Antonarakis ES
    Prostate; 2019 Sep; 79(13):1572-1579. PubMed ID: 31389628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
    Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
    Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.
    Dominguez-Valentin M; Joost P; Therkildsen C; Jonsson M; Rambech E; Nilbert M
    BMC Urol; 2016 Mar; 16():15. PubMed ID: 27013479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
    Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR
    Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens.
    Akbari MR; Zhang S; Cragun D; Lee JH; Coppola D; McLaughlin J; Risch HA; Rosen B; Shaw P; Sellers TA; Schildkraut J; Narod SA; Pal T
    Fam Cancer; 2017 Jul; 16(3):351-355. PubMed ID: 28176205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
    Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP
    Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characterization of Mismatch Repair Gene-Deficient Metastatic Castration-Resistant Prostate Cancer.
    Ye S; Wang H; He K; Peng M; Wang Y; Li Y; Jiang S; Li J; Yi L; Cui R
    Front Oncol; 2020; 10():533282. PubMed ID: 33117677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers.
    Geurts-Giele WR; Leenen CH; Dubbink HJ; Meijssen IC; Post E; Sleddens HF; Kuipers EJ; Goverde A; van den Ouweland AM; van Lier MG; Steyerberg EW; van Leerdam ME; Wagner A; Dinjens WN
    J Pathol; 2014 Dec; 234(4):548-59. PubMed ID: 25111426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSH2 Loss in Primary Prostate Cancer.
    Guedes LB; Antonarakis ES; Schweizer MT; Mirkheshti N; Almutairi F; Park JC; Glavaris S; Hicks J; Eisenberger MA; De Marzo AM; Epstein JI; Isaacs WB; Eshleman JR; Pritchard CC; Lotan TL
    Clin Cancer Res; 2017 Nov; 23(22):6863-6874. PubMed ID: 28790115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.